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Background: The literature surrounding anterior cruciate ligament (ACL) reconstruction (ACLR) 
exhibits the most commonly used grafts for a ruptured ACL are bone- patellar tendon- bone 
(BPTB) autografts, quadriceps tendon (QT) autografts, hamstring tendon (HT) autografts, and 
allografts. This paper was designed to compare the postoperative outcomes between autografts 
and allografts to determine which graft is superior.  
Methods: A literature review of studies were searched and selected based on inclusion and 
exclusion criteria using Augsburg University Interlibrary loan system, PubMed, and Elsivier. 
Results: The research demonstrates superior outcomes for autografts compared to allografts. 
Additionally, the research delineates outcomes based on the type of autograft used in ACLR. The 
literature describes BPTB autografts as having decreased laxity and failure rates compared to 
other autografts. The literature also suggests specific indications for autografts and allografts. 
Autografts have demonstrated decreased rates of graft failure and laxity, and are associated with 
better postoperative functional outcomes. Autografts are the graft of choice for younger, more 
active patients, but have been associated with increased donor-site morbidity including hamstring 
weakness, anterior knee pain, and hypoesthesia. Allografts are associated with increased laxity 
and graft failure, but are noted to have better subjective outcomes based on less donor-site 
morbidity.  
Conclusion: Overall, autografts have been validated to be the superior graft choice when it 
comes to laxity and failure rates for younger and more active patients, but allografts have their 
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own indications for older, less active patients looking to maintain knee function without risking 
the complications associated with autograft harvest. 
INTRODUCTION 
 
ACL tears are common injuries, with more than 200,000 tears and an estimated 100,000 
ACLRs performed each year in the United States1. Data collected from patients under 65 years-
old from January 1, 2005 to December 31, 2013, found the average cost associated with an ACL 
reconstruction is $13,403.38 with insurance2. Considering the prevalence of ACL tears within 
the population and the cost of reconstruction the relevance of this topic is easily explained.  
The most common surgical treatment for an ACL tear is an ACLR. The ACLR has been 
the gold standard treatment for ACL tears since the 1980’s. This includes using tendon grafts to 
replicate the anatomy and function of the ACL. The two main types of grafts used for ACLR are 
autografts and allografts1. Autografts are tendons that are harvested from the patient and used to 
reconstruct the torn ACL. There are multiple sites for graft harvest in reconstruction. The most 
commonly used graft sites are the hamstring, patellar tendon, and quadriceps tendon. Conversely, 
an allograft comes from a donor cadaver. These grafts are sterilized in a variety of ways, but 
most common is gamma irradiation1,3. 
The purpose of this paper is to establish if ACLR using an autograft versus an allograft 
provides superior post-surgical outcomes in patients with a torn ACL. This will be evaluated by 
comparing subjective outcomes, objective outcomes, and associated complications with 
autografts versus allografts in regards to ACLR. Understanding the basis of how the knee is 
evaluated is helpful when interpreting results within the research. Historically, approaches to 
evaluate knee function relied on objective findings, such as radiologic evaluation, strength, range 
of motion (ROM), and laxity4. While objective measurements hold value in the assessment of 
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knee function and are used for data in studies, patient-oriented questionnaires are just as 
significant. The subjective questionnaires allow patients to rate different aspects of how their 
knee feels and functions. The rating systems, or functional outcome scores, use subjective data 
provided by patients as well as objective measurements to determine a score4-6.  From there, 
researchers can compare the pre-operative versus post-operative scores to help determine the 
risk-benefit profile of each intervention. The most commonly used rating systems that were 
utilized in research studies and will be presented and referenced throughout this paper are the 
International Knee Documentation Committee (IKDC), Lysholm Scale, Tegner Activity Score 
(TAS), and Cincinnati Knee Rating System (CKRS).  
Moving on from the subjective assessments, objective tests are designed to measure knee 
function and take out the subjectivity that occurs with the scoring based rating systems. There are 
a variety of tests to put stress on the knee ligaments to determine instability that include the 
pivot-shift, Lachman, and anterior drawer tests. Another objective assessment that has been the 
most widely studied and is considered the gold standard for laxity measurement is the KT 
arthrometer7. To provide context of these objective tests, they will be referenced throughout this 
paper. 
BACKGROUND RESEARCH 
Prior to comparing and contrasting the different grafts, a review of knee anatomy, 
specifically the ACL, is necessary. Following the anatomy review, an in-depth explanation of 
each assessment for evaluating postoperative knee outcomes will be provided. Then, a 
comparison of outcomes between the types of autografts used in ACLRs will be discussed. After 
the discussion comparing the outcomes between the types of autografts, the allografts options for 
ACLR will be briefly mentioned. Finally, the main purpose of this paper comparing the 
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outcomes between autografts versus allografts in general will be investigated before comparing 
the outcomes based on the specific types of autografts and allografts.  
The anterior cruciate ligament (ACL) provides rotational and translation stability to the 
knee. It stabilizes the tibia from displacing anteriorly in relation to the femur. There are two 
bundles that comprise the ACL. The anteromedial bundle (AM) is responsible for stability in the 
anterior-posterior direction and is the tightest in flexion. The posterolateral (PL) bundle is 
responsible for rotational stability and is the tightest in extension (Fig. 1)8. The ACL receives its 
blood supply from the middle geniculate artery by way of the periligamentous vessels which 
form a network in the synovial membrane. It has the most vasculature at the proximal portion 
compared to the middle and distal segments of the ligament8. The ACL derives its nerve 
innervation from the articular branch of the tibial nerve8. With an understanding of ACL 
anatomy, the management and the history of a knee injury will now be established.  
Initial management of a knee injury is to perform a history and physical exam of the 
patient. Obtaining a thorough history will direct you to the diagnosis but a workup of the injury 
is required, nonetheless. The most common presentation of a torn ACL is a patient stating that 
when they planted their foot and turned, they heard a “pop” and felt pain. The next step to 
managing a knee injury is to obtain high-quality images of the structures within the knee. The 
imaging modality to accomplish this is magnetic resonance imaging (MRI). An MRI allows the 
most detailed look at the structures of interest inside the knee. Now that the management of a 
knee injury has been clarified, an examination of the assessment tools to evaluate postoperative 
outcomes will be described. 
To begin, there has been an association with hamstring tendon (HT) autografts of 
increased stretching leading to laxity and graft failure. Laxity can be measured using a few 
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different methods. There are three dichotomous tests that will be mentioned throughout this 
paper. They are the Lachman, anterior drawer, and pivot-shift tests. The Lachman and anterior 
drawer test the laxity of the ACL by pulling on the posterior surface of the knee and trying to 
displace the tibia anteriorly in relation to the femur. The difference between the tests is the 
degree of flexion of the knee while performing the maneuver. The Lachman test has the patient 
lying supine with their knee flexed at 30 degrees while performing the maneuver. The anterior 
drawer has the patient supine as well, but this time the knee is flexed to about 90 degrees while 
performing the maneuver. The pivot shift test is a dichotomous test designed to put stress on the 
new ligament. It uses internal rotation and valgus stress to evaluate rotational stability as the 
tester takes the knee from full extension to flexion to replicate the movement pattern when ACL 
injury occurred9. A positive test occurs if the patient has pain, clunking or instability.  
The drawback to these tests is they are supposed to be objective tests, but there is a fair 
amount of subjectivity to them. The difficult part of using these assessments is they rely on the 
assessor to estimate the amount of displacement of the tibia anteriorly. These estimates are the 
inaccurate measurements of laxity. Fortunately, technology has allowed us to create a way to 
eliminate the subjectivity of these tests.  
The more reliable instrument to objectively assess knee laxity, specifically the ACL, is 
with an arthrometer. Arthrometers allow for reproducible results that are quick, easy, and 
increase objectivity compared to a clinical exam7. The KT-1000/KT-2000 arthrometer takes out 
the subjectivity of Lachman’s and anterior drawer tests as it gives a measurement in millimeters 
of anterior laxity. The patient lies supine with the KT arthrometer attached to the leg (Fig. 2)7. 
Forces are then applied and the arthrometer measures the maximal anterior translation. Although 
the validity and reliability of KT arthrometry has been criticized, increased forces applied by the 
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arthrometer generate valid measurements in sensitivity 93% and specificity 91%10. In ACL 
patients with intact ACLs, reliability ranged from intra-raters and inter-tester correlations from 
0.83 to 0.97 and 0.41 to 0.92, respectively7. Discrepancies in measurements of as little as 2-3mm 
can diagnostically skew results and therapeutically alter treatment course, thus, the motivation to 
combine subjective patient data with the objective measurements and tests. The evaluation and 
assessment of the knee injury is a key driver to the indications of appropriate graft selection. 
Another assessment method described in the literature is subjective evaluation. 
Subjective evaluation has proven as important and objective measurements in comparing 
postoperative outcomes. One such assessment that has been subject to rigorous statistical 
evaluation and has proven to be a valid and responsive patient-reported outcome measure is the 
IKDC4. The IKDC subjective knee form was created by a committee of knee experts from 
around the world to standardize the evaluation of patient outcomes post-knee surgery or 
treatment. The form contains 18-items and focuses specifically on the knee. The questions are 
based on symptoms assessing pain, stiffness, swelling, joint locking, and joint instability. The 
other areas it assesses are the ability to perform daily and sports activities like running, jumping 
and landing, stopping and starting quickly, going up and down stairs, standing, kneeling on the 
anterior aspect of the knee, squatting, sitting with the knee bent, and rising from the chair4. The 
patient responses include “yes-no”, while others are on standard Likert scales of 5 points, and 11 
points. Total score is calculated by the sum of responses, divided by the maximum possible 
score, times 100, to give a maximum total score of 100. The lower scores correlate with higher 
symptoms or lower function level. 
An additional subjective assessment that was created by sports medicine surgeons 
primarily to evaluate outcomes of knee ligament surgery is the revised Lysholm Scale5. The 
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current version consists of eight items that measure pain, instability, locking, swelling, limp, stair 
climbing, squatting, and need for support. The responses are scored differently based on the item, 
but the total is out of 100. The lower scores correlate with higher symptoms or disability. In 
patients with mixed knee pathologies, the Lysholm scale is not reliable, but is consistent with 
grouped knee injuries5. The Lysholm scale has been validated as scores have correlated with 
other knee scoring systems5.  
Complimentary to the Lysholm scale, the TAS was created to assess patients with ACL 
injuries as the Lysholm scale has limitations in its evaluation of functional scores. The scoring is 
based on level of activity. A score of 0 represents missing work due to knee issues, and a score 
of 10 corresponds to competing in national level sporting events. Patients may only respond with 
a 6-10 if they actively participate in recreational or competitive sports5. The validity and 
reliability of the TAS is adequate and has demonstrated correlation to other knee scoring 
systems5. 
The final functional outcome scoring system that will be described in this paper is the 
CKRS. The CKRS contains items on a questionnaire that include symptoms, functional 
limitations with sports and daily activities, patient perception of knee condition, and sport- and 
occupational-activity levels. The CKRS have proven to be highly effective in detecting changes 
in knee evaluations, and acceptable reliability, validity, and responsiveness for the assessment of 
knee function6. With an understanding of the various ways to assess knee function, the research 
on the treatment of an ACL tear using ACLR will be discussed. 
Traditionally, the gold standard surgical treatment of an ACL tear has been the ACLR 
using tendon grafts. There have been numerous studies to determine if autografts or allografts for 
an ACL tear is indicated. The research describes the most commonly used autografts are the HT 
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(semitendinosus and gracillis), bone- patellar tendon- bone (BPTB), and quadriceps tendon 
(QT)11, 12. The outcomes associated with ACLR based on the location of donor autograft tendon 
used will be investigated next.  
HT versus BPTB autografts 
Persson et al reported an increase in graft failure with HT autograft compared to patellar 
tendon autograft in patients with at least 5-years follow-up. Persson et al was a retrospective 
cohort study with a mean follow-up of 4.0 years. The study included 12,643 primary ACLRs, 
with 3428 patellar tendon and 9215 HT grafts. There were 69 revisions with patellar tendon 
grafts and 362 revisions with HT grafts13. A higher revision rate was recorded for the HT group 
versus the patellar tendon group at all follow-up times as patients with HT grafts had twice the 
risk of revision compared with patients with patellar tendon grafts13. The younger age was the 
most important risk factor for revision, and no effect was seen for sex13. 
In contrast, Edgar et al. concluded HTs are as effective as BPTB grafts in strength and 
stiffness. A majority of studies found HT autografts to have less anterior knee pain, and less 
donor site morbidity compared to BPTB autograft14. Other studies also describe hamstring 
weakness as main contributor to hamstring tendon morbidity14. The research comparing patient 
outcomes of HT autograft versus BPTB autograft does not demonstrate a superior site for graft 
harvest. The decision to choose which location for the donor autograft is patient specific, and is 
determined by multiple factors. 
QT versus BPTB autografts 
Further comparison between the types of autografts that can be used in ACLRs to 
delineate a superior graft choice for ACL tears is warranted. Thus, a study by Mouarbes et al. 
compared outcomes of ACLRs using QT versus HT, and BPTB versus HT autografts in a 
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systematic review and meta-analysis. The analysis included 27 studies with a total of 2,856 
patients with a minimum follow-up duration of 12 months. In regards to QT versus BPTB 
outcomes, the study found no difference in stability, measured by arthrometry (p= 0.45), 
Lachman (p= 0.76), and pivot-shift (p= 0.23). The study found no difference in functional 
outcome scores of objective IKDC (p= 0.20), subjective IKDC (p= 0.36), and Lysholm (p= 
0.10). Finally, the study did not elucidate a significant difference (p= 0.50) when comparing 
failure rates between the two groups, but the study demonstrated QT autograft was favored (p< 
0.00001) in regards to donor-site pain over BPTB.  
QT versus HT autografts 
Additionally, the Mouarbes et al. study investigated the outcomes of QT autograft versus 
HT autograft in ACLR. The stability outcomes demonstrated no significant difference, measure 
by arthrometry (p= 0.75), Lachman (p= 0.41), and pivot-shift (p= 0.44). The study did 
demonstrate a significant difference in regards to the Lysholm functional outcome score favoring 
QT autograft over HT autograft. Other functional outcome scores did not elucidate any 
significant difference between QT versus HT autografts. The analysis did no demonstrate a 
significant difference in regards to anterior knee pain (p= 0.40), or graft failure (p= 0.46). 
Allografts 
As for allografts, they come in a variety of options. The allografts used in most studies 
are fresh-frozen hamstring, irradiated hamstring, mixture of fresh-frozen, and cryopreserved 
hamstring, fresh-frozen tibialis anterior, and fresh-frozen Achilles tendon grafts12. The 
implication of the preservation method used for allografts will be discussed later in this paper. 
With the wide array of tendon choices, it can be difficult deciding the best option for each 
patient. 
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Autografts versus allografts 
After comparing the outcomes between the different types of autografts, the primary 
purpose of this paper is to compare the patient outcomes between tendon autograft versus 
allograft in ACLR. One study investigated autografts versus allografts in ACLR, but did not 
separate the type of autografts or allografts used in their meta-analysis. This was a meta-analysis 
and systematic review by Wang et al.1 that included six studies with a combined total of 18,835 
patients (14,862 autografts versus 3973 allografts). They determined there was no significant 
difference between autograft and allograft groups in regards to overall IKDC (p=0.21), ROM 
(p=0.94), vertical jump (p=0.09), and single-legged hop (p=0.50) testing1.  The other objective 
measurements including KT-2000 (p< 0.0001), pivot-shift (p= 0.001), anterior drawer (p= 
0.0001), and Lachman’s (p= 0.0002) testing from 215 patients favored autografts compared to 
allografts1.   
The meta-analysis then compared the subjective outcome scores of the studies. They 
found the subjective IKDC (p< 0.0001), Lysholm (p= 0.01), and TAS (p= 0.03) from 279 
patients demonstrated significant differences favoring autografts compared to allografts1. The 
study also found CKRS from 215 patients favored autografts over allografts (p= 0.04)1.  
The postoperative complications associated with ACLRs in studies comparing autografts 
and allografts found two patients from one of the studies developed a superficial wound infection 
in the allograft group1. Additional postoperative complications were reported in five patients 
from two studies that developed hypoesthesia of the medial saphenous nerve in the autograft 
group1. In four studies that investigated complications, they reported only two studies with 
associated complications with either autograft or allograft groups1. There was no significant 
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difference found when comparing complications between the autograft and allograft groups, but 
the risk ratio favored the allograft group (0.48, p= 0.34)1.  
In addition to postoperative complications, the irradiation of allografts have shown to 
compromise the integrity of the graft, thus leading to less stability and potentially higher failure 
rates than fresh-frozen allografts or autografts1. There were 302 autograft failures and 157 
irradiated allograft failures reported from two prospective cohort studies1. There were no 
reported failures in the three randomized controlled trials1. Therefore, a meta-analysis could not 
be performed due to the differing levels of evidence between the five studies. Other research 
shows increasing ACLR failure rates using allografts in younger patients and increased activity 
levels16.  
While studies comparing outcomes between all autografts versus all allografts 
demonstrate autografts superior to allografts, further research comparing the different types of 
grafts used in ACLR is necessary. 
BPTB autografts versus allografts 
First, BPTB autografts are considered the current gold standard for ACLR. Studies 
comparing outcomes of BPTB autograft versus BPTB allografts favored autografts over 
allografts. A contributing factor of BPTB autografts being gold standard has to do with the lower 
failure rates associated with BPTB autografts compared to allografts from multiple studies17, 18. 
The largest study concluded the graft rupture rate favored autografts at 4.3% compared to 12.7% 
for the allograft group17. Kraeutler et al. was a meta-analysis of 76 studies of 5182 patients (4276 
autografts versus 906 allografts) with minimum of 2 years follow-up comparing only BPTB 
grafts. The study included data from patients between January 1998 to April 2012. The studies 
ACL reconstruction    14 
did not need to be comparative in nature, and dichotomous variables were summarized as odds 
ratios with less than 1 favored allograft, and greater than 1 favored autografts. 
A smaller cohort study by Barrett et al. included 63 total patients over 40 years-old 
between April 1, 1999 and October 1, 2000 with 2 years follow-up minimum. The study 
observed allograft failure in 1 patient, and two other allograft patients reported positive 
Lachman’s, pivot-shift, and 6mm KT-1000 side-to-side arthrometer difference18.Those patients 
did not consider those results as failures and did not proceed with any interventions18. There 
were no failures in the autograft group18. No deep infections, neurological complications, or 
wound problems in either group18. 
While the objective findings and failure rates favored autografts, subjective evaluation 
reported from 17 studies, showed allograft patients returning to preinjury activity level faster 
than autograft patients17. In a retrospective review of 102 patients (63 autograft versus 39 
allografts) using BPTB autograft or allograft sterilized with 2.5 Mrad of irradiation found no 
significant difference in subjective ratings as 95% of allograft patients and 98% of autograft 
patients rated their knee function as normal or near normal. Furthermore, 95% of allograft 
patients compared to 94% of autograft patients rated their activity levels as back to normal or 
near normal19. The study had an average follow-up of 4.2 years19. There were 10 studies 
evaluating the subjective IKDC and found the odds ratio (1.64) favored autografts17. Other 
functional scores found Lysholm odds ratio (2.61) from 21 studies and TAS odd ratio (1.35) 
from 12 studies significantly favored autografts17. While other studies, at final follow-up, found 
no difference between groups in regards to Lysholm scores (p= 0.081), and TAS (p= 0.127)18. 
There was no statistically significant difference between autograft and allograft groups with 
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respect to the CKRS17. Overall IKDC odd ratio (0.45) from 37 studies, significantly favored 
allografts17. Rihn et al. found no difference in IKDC between groups. 
Objective evaluation from 45 studies, demonstrated the pivot-shift test odds ratio (0.74) 
favored allografts17. KT arthrometer odds ratio (2.02) from 38 studies, and single-legged hop test 
odds ratio (4.09) from 16 studies significantly favored autografts17. Conversely, another study 
found the allograft group had decreased KT arthrometry (p= 0.04) compared to autograft 
group19. Furthermore, Rihn et al. found no difference in ROM, vertical jump, or single-legged 
hop tests between autografts and allografts. Similarly, another study’s objective findings 
revealed no difference in Lachman’s (p= 0.096), pivot-shift (p= 0.245), ROM , or KT-1000 (p= 
0.398)18.  There were 28 studies evaluating anterior knee pain and found the odds ratio favored 
allografts17.  
QT autograft versus allograft 
Next, outcomes of quadriceps tendon autografts versus allografts will be compared. In the 
current literature, there is only one study comparing QTPB autografts to QTPB allografts. Kwak 
et al. included patient data from February 2009 to January 2014. The study was a retrospective 
matched case control study for age, sex, direction of injured knee and BMI of 45 patients 
receiving QTPB autograft and 45 patients receiving QTPB allograft. The average follow-up was 
31.2 months.  
Kwak et al. found no difference between autograft and allografts at final follow-up in 
regards to objective tests including anterior drawer (p= 0.652), Lachman’s (p= 0.404), pivot-shift 
(p= 0.823), and KT-2000 (p= 0.235). Instability assessment scores improved in both groups (p< 
0.001).  One patient in each group demonstrated clinical failure with positive Lachman’s test, but 
both patients' anterior drawer, pivot-shift, and KT-2000 measurements did not elicit instability. 
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Functional score outcomes including IKDC (p= 0.366), Lysholm (p= 0.170), and TAS 
(p= 0.434) also found no difference between the groups. Functional improvements were 
observed in both groups from preoperative to postoperative assessments (p< 0.001). 
HT autografts versus allografts 
Finally, the outcomes of HT autografts versus allografts will be compared. A study by 
Cvetanovich et al. found no difference between autografts and allografts in Lysholm (p= 0.53), 
TAS (p= 0.40), and IKDC (p= 0.80) scores12. Cvetanovich et al. was a systematic review and 
meta-analysis of randomized control trials comparing HT autograft versus allograft ACLR. The 
analysis included five studies (504 total patients) with 251 patients receiving autografts and 253 
receiving allografts with a minimum of  2 years follow-up. The allografts used were fresh-frozen 
hamstring, irradiated hamstring, mixture of fresh-frozen and cryopreserved hamstring, fresh-
frozen tibialis anterior, and fresh-frozen Achilles tendon. 
Similarly, a prospective study by Edgar et al. comparing HT autografts versus allografts 
demonstrated no difference in Lysholm (p= 0.75), overall IKDC (p= 0.51), or TAS (p= 0.08) 
scores14. Edgar et al. was a prospective study including 104 patients (37 autografts versus 47 
allografts) from 1997 to 2000. The study included skeletally mature patients between 15-55 years 
old, average age 29 years. The excluded patients had prior ACL or other ligamentous injury to 
either knee, and concomitant MCL, LCL, or PCL injury or other bony/cartilaginous repairs. The 
patient follow-up was a minimum of 3 years. The patients were informed of the autograft and 
allograft constructs and 75% consented to randomization for the study. The non-randomized and 
randomized groups were pooled to ensure validity of the study. The postoperative rehabilitation 
protocol was identical in both groups of patients, and clinical assessments were performed by 
blinded observers to the graft type of the patients.  
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Edgar et al. found preoperative average Lysholm scores were 71.3 and 67.7 for autograft 
and allograft groups, respectively. At final follow-up, the Lysholm scores improved to 91.0 and 
92.7, respectively. In addition, average subjective IKDC scores improved from 57.5 to 87.6 and 
54.9 to 87.0 for the autograft and allograft groups, respectively. The average TAS from preinjury 
to final follow-up was 7.2 to 6.8 and 6.8 to 6.9 for autograft and allograft groups, respectively. 
There were two patients in the autograft and two in the allograft group with failed grafts 1 year 
post-operation sustained injuries while playing sports. 
Additionally, Wang et al.11 found no difference in the Lysholm or overall IKDC scores 
between the HT autograft and allograft groups, but did elucidate differences in subjective IKDC 
and TAS favoring autografts. Subjective IKDC (p= 0.0006) and TAS (p= 0.03) showed a 
significant difference favoring HT autografts. Wang et al.11 was a meta-analysis including eight 
studies (785 patients). All studies had at a minimum of 2 years follow-up, and were randomized 
patients using HT autografts and hamstring, tibialis anterior, tibialis posterior, or Achilles tendon 
allografts. The autografts were fresh-frozen, with three studies using irradiated allografts. The 
objective testing will be evaluated next as there is no clear indication for HT autograft versus 
allograft in regards to subjective assessment. 
The objective tests comparing HT autografts versus allografts reveal no significant 
differences between HT allograft and autograft for Lachman’s (p= 0.16), pivot-shit (p= 0.46), 
and KT arthrometer testing (p= 0.36)12. Other studies with similar results did not note any 
difference in stability outcomes of ROM, pivot shift test, anterior drawer test, and Lachman’s 
test11. The arthrometry measurements did note a significant difference (p= 0.01) between the 
groups, favoring HT autografts11. At final follow-up, Edgar et al. did not elucidate the difference 
in KT measurements between HT autografts and allografts (p= 0.33), but both groups did show 
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improvement in laxity (p< 0.0001). Preoperative and final follow-up KT measurements were 6.0 
to 1.4 and 5.9 to 1.5 in the autograft and allograft groups14. The arthrometer measurements were 
maintained upon 3 year follow-up in 87% of autograft and allograft groups14. The comparison of 
the complications associated with HT autograft versus allograft will now be discussed. 
The most common complication of ACLR using a HT autograft is donor site morbidity11, 
12. HT autograft harvest site morbidity includes saphenous nerve damage and postoperative knee 
flexion weakness12. Studies have also found longer operating time for HT autografts compared to 
allografts11, 12. Although an increase in the reoperation rates for autografts compared to allografts 
was noted, it was not statistically significant12. There is a possible risk for disease transmission, 
delayed graft incorporation, graft laxity, and failure with prolonged use in allografts12. 
Wang et al.11 did not find any differences between the groups in regards to other 
complications such as reoperation, pain, arthrofibrosis, effusion, tenderness, or infection. A 
postoperative complication of ACLR was hypoesthesia of the medial saphenous nerve using HT 
autograft that showed a significant difference (p= 0.01) in favor of allografts.  
Of note, four of 396 HT autografts and 13 of 389 allograft failures were reported11. No 
significant difference (p= 0.81) in reoperation rate between the two groups as there were 7 in the 
autograft and 6 in the allograft group12. Failure rates included patients with laxity greater than 
4mm with 5% compared to 11% in autograft versus allograft groups14. Three patients from the 
autograft and two from the allograft failure groups underwent revision surgery14. 
Based on the research findings, autografts are superior in regards to lower failure rates 
compared to allografts, but have an increase in donor-site morbidity. Thus, indications for use of 
autografts versus allografts remains to be a patient-centered decision, and risk factors must be 
taken into consideration. 
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METHODS 
Research was done by searching Augsburg University Interlibrary loan system, PubMed, 
and Elsiver to identify studies that compared autograft compared to allograft tendon repair in 
ACL reconstruction. Title fields were searched for the following terms in each database: “ACL 
reconstruction”, “Autograft”, “Allograft”, “BPTB autograft versus allograft”, “Quadriceps 
tendon autograft versus allograft”, “Measures of knee function”, “Cincinnati knee score”, and 
“ACL repair”. A manual search was also performed for “pivot-shift scholar”, and “cost of ACL 
reconstruction”. Additionally, a manual search was performed for articles potentially missed by 
the electronic search. The studies included were based on selection criteria. The studies were 
reviewed for information pertaining to first author, publication year, study type, sample size, age 
(closed physes), sex ratio, information regarding the tendon autografts or allografts. Primary 
outcomes studied were subjective patient evaluations including IKDC, Lysholm, TAS, CKRS 
and post-operative pain score, and objective assessments including: ROM, anterior knee pain, 
KT arthrometer, single-legged hop, vertical jump, and associated complications/failures. 
The studies included meta-analyses, systematic reviews, prospective cohort, and 
retrospective studies. There were a total of 120 studies included for meta-analysis, 30 studies for 
systematic review, 4 prospective cohort studies, and 3 retrospective cohort studies.. This 
included a total of 41,164 patients. The dates of the studies from database searches ranged from 
database inception to 2018 with a minimum follow-up duration of 1 year post-operation.  
Excluded studies were any with less than 1 year duration follow-up post-operation. Other 
inclusion and exclusion criteria were study specific, and are mentioned within this paper. 
DISCUSSION 
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Recalling the high prevalence and cost associated with ACL tears and reconstructions, an 
understanding that the best outcomes are ideal for patients to ensure knee function is restored and 
pain is eliminated.  First, the comparison of outcomes between the types of autografts used in 
ACLRs will be discussed. Then, the comparison of the outcomes between autografts versus 
allografts will be examined before the comparison of the outcomes based on the types of 
autografts and allografts. 
HT vs BPTB auto 
The literature with the most robust cohort study and longest duration of postoperative 
follow-up demonstrates BPTB autograft to be associated with decreased revision rates and graft 
failure compared to HT autograft13. Other studies have demonstrated HTs to be non-inferior to 
BPTB autografts with less anterior knee pain, but did note an increase in hamstring weakness14. 
QT vs BPTB auto 
The study by Mouarbes et al. comparing the outcomes between QT and BPTB autografts 
found no difference in stability, measured by arthrometry, Lachman, and pivot-shift. 
Furthermore, there was no difference in functional outcome scores of objective and subjective 
IKDC, and Lysholm. Additionally, there was no difference found in regards to failure rates, but 
did note that QT was favored in regards to donor-site morbidity over BPTB. 
QT vs HT auto 
In the same study by Mouarbes et al., they compared the outcomes between QT and HT 
autografts. The study found no difference in stability, measured by arthrometry, Lachman, and 
pivot-shift. There was no difference in other functional outcome scores except Lysholm which 
favored QT over HT. Finally, there was no difference elucidated between QT and HT autografts 
in regards to anterior knee pain or graft failure. 
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Autograft vs allograft 
Before diving into the comparison of outcomes between the types of autografts versus 
allografts, a general comparison of outcomes of autografts versus allografts will be elucidated. 
Autografts were favored in KT, pivot-shift, anterior drawer, and Lachman tests1. Additionally, 
autografts were favored in subjective IKDC, Lysholm, TAS, and CKRS1. Arguably the most 
important outcome measured in the Wang et al.1 study that favored autografts was failure rates 
when compared to irradiated allografts. The Wang et al.1 study found no difference between 
autografts and allografts in regards to objective IKDC, ROM, vertical jump and single-legged 
hop. There was no difference in complications observed, but the risk ratio favored allografts.  
The tests examining anterior and rotational stability of the knee showed significant 
differences between the preservation and sterilization allograft groups. As previously noted, 
allografts are preserved in a variety of ways, and studies have proven increased gamma 
irradiation to have detrimental effects on the properties of allografts leading to significantly poor 
rotational and anterior stability compared to autografts1, 21-23.  The irradiation of allografts have 
been shown to cause adverse effects in a dose-dependent manner as a reduction in biochemical 
effects on allografts is seen under 2 Mard of gamma irradiation1, 11. 
Additionally, the type of preservation and sterilization method significantly impacts 
which graft the patient chooses. Studies were not able to demonstrate enough evidence to 
delineate which graft failure rate was higher, but decreased stability was associated with gamma 
irradiation on allografts1, 11. The failure rate of the Wang et al.1 study could not be evaluated due 
to the differing levels of evidence. In addition, there were no reported failures in three of the 
randomized control trials out of the data from five included studies. More randomized control 
trials are needed to compare the failure rates between autografts and allografts.  
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Other comparative studies have demonstrated higher failure rates in gamma-irradiated 
allografts1. The observed 33% failure rate and increased KT-1000 measurements in irradiated 
allografts compared to a 2.4% failure rate in non-irradiated allografts validate the detrimental 
effects of gamma-irradiation on allografts24. 
In an interview on July 27th, 2021, Dr. Nicholas Weiss, an orthopedic surgeon with Twin 
Cities Orthopedics, commented on how he chooses his graft selection based on age.  
For older folks allograft is appealing as they will likely have a good result and the morbidity of 
harvest is eliminated. Studies show that an allograft for younger patients has a high failure rate.  
Likely because of the increased stress placed on the graft with higher level activities. Weekend 
warriors or ‘older’ patients are reasonable for allograft.  Allograft is unpredictable in quality and 
weakens with preparation so I have moved away from it for most. 
BPTB auto vs allo 
The first type of autograft that will have its postoperative outcomes compared to 
allografts is the BPTB autograft. BPTB autografts demonstrated lower failure rates compared to 
allografts17, 18. Barrett et al. also found BPTB autografts had decreased laxity as measured by 
arthrometry, Lachman, and pivot-shift tests compared to allografts. Other studies found 
subjective IKDC, Lysholm, and TAS to favor BPTB autografts over allografts, but did not 
elucidate differences in CKRS17.  
There was no difference in the functional outcome scores of Lysholm or TAS18, 19. Rihn 
et al. also did not find a difference in other knee ratings or activity levels between groups as knee 
function and activity level ratings were normal to near normal. No differences were elucidated in 
ROM, vertical jump, or single-legged hop in the Rihn et al. study. The objective measurements 
demonstrated KT arthrometry, single-legged hop to favor autografts over allografts17. 
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Allografts were favored over BPTB autografts in preinjury return to activity. Barrett et al. 
noted the return to preinjury activities was limited in this study due to the age group, but 56% of 
allograft and 25% of autograft patients were back to sporting activities by 6 months. There were 
also fewer autograft patients able to return to preinjury activities at the time of follow-up in the 
Kraeutler et al. study. Additionally, Kraeutler et al. found the overall IKDC to favor allografts 
over BPTB autografts. Other assessments favoring allografts over autografts were arthrometry19 
the pivot-shift test17, and subjective assessment of knee pain17.  
The study by Kraeutler et al. demonstrated the pivot-shift test favored allografts versus 
autografts only when the reconstruction was performed using an anteromedial approach. 
However, further investigation revealed a higher proportion of the autograft reconstructions used 
the trans-tibial approach when compared to allograft reconstructions. The surgical technique did 
not demonstrate a difference in pivot-shift when comparing anteromedial and outside-in 
approaches to a transtibial approach. 
QT auto vs allo 
The next comparison of outcomes to allografts are the QT autografts. The current 
literature demonstrates no difference in laxity or stability as measured by anterior drawer, 
Lachman, pivot-shift, and KT arthrometry20. In the study, both groups showed an increase in 
stability post-operation20. Additionally, the study found no difference in functional outcomes 
scores20.  
HT auto vs allo 
Finally, the comparison of outcomes between HT autograft versus allografts. Significant 
differences favoring HT autografts over allografts were demonstrated in the functional outcome 
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scores of IKDC, and TAS 11. The objective assessments that favored autografts were KT 
arthrometry11. 
The research demonstrates no difference in Lysholm, IKDC11, 12, 14 and TAS14. Research 
noted improved functional outcome scores in both HT autograft and allograft groups post-
operation14. Objective outcomes also showed no difference in stability and laxity as measured by 
Lachman12, anterior drawer11, pivot-shift11, 12, ROM11, pivot-shift11, and KT arthrometry12, 14. 
Even though there was no significant difference between the groups, the groups demonstrated 
improvement in laxity and maintained those measurements for 3 years14. Furthermore, there was 
no difference appreciated in regard to reoperation rates12, pain, arthrofibrosis, effusion, 
tenderness, or infection11 between HT autograft and allografts  
 The complications associated with HT autografts are well documented. Saphenous nerve 
damage, knee flexion weakness11, 12. Also, longer operation time was associated with HT 
autografts compared to allografts. On the contrary, allografts have been associated with 
complications such as disease transmission, delayed graft incorporation, and graft laxity and 
failure12. 
A central challenge most of the studies touched on was the need for more high-quality, 
randomized control trials with more patients, and longer follow-up to help determine which graft 
choice definitively provides superior outcomes. Some of the studies included a small number of 
randomized control trials that researchers were able to utilize. This also included some data that 
had a small sample size. For a definitive conclusion to be made, there needs to be a large enough 
sample size that allows statistical significance to be relevant. Statistically significant results from 
studies with small sample sizes do not carry the same weight as studies with a more robust 
sample size.  
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Furthermore, most of the studies had follow-up duration of only two years post-operation. 
While this gives an insight into short- to intermediate-term outcomes, it does not provide 
sufficient assessment of the long-term outcomes of autografts and allografts in ACLR.  Also, 
most of the studies included patients of varying demographics, but there were studies that only 
investigated the outcomes of certain age groups. This is helpful to gain an understanding of that 
specific patient population, but the results of the study cannot be extrapolated to other age 
groups.  
Another important limitation to the current research is lack of standardization of 
comparison between grafts. Comparing the same types of grafts between patient cohorts (ie 
BPTB autografts versus BPTB allografts) increases the study’s validity of results. It is imperative 
to comprehensively formulate a database where researchers can select the types of grafts to 
compare. Additionally, standardization of the evaluation of patients is necessary. Some studies 
were excluded due to the fact they had no preoperative rating scales to compare the postoperative 
ratings to. This is a real disadvantage and hinders the scientific method. 
CONCLUSION 
When an ACL is torn and an ACLR is the treatment selected by the patient and surgeon, 
it is imperative to understand which graft choice provides superior outcomes. The primary 
objective of this paper was to determine superior post-operative outcomes of autografts versus 
allografts in patients with ACL tears. Specifically, this paper addressed the outcomes based on 
subjective rating scales, objective measurements, and the complications observed in patients with 
short- to intermediate-term follow-up. The large studies demonstrate autografts the superior graft 
choice over allografts in overall postoperative ACLR outcomes. The data is not consistent across 
the smaller studies with respect to each individual outcome category (i.e. subjective, objective, 
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and failures), but the overall trend demonstrates allografts to be equal or inferior to autografts in 
most categories. In addition to the overwhelming evidence supporting autografts superior to 
allografts in almost every outcome, other differences must be considered to support the autograft 
construct superior.  
Dr. Weiss was asked about his approach to an ACLR for a patient with a torn ACL.  
Age isn't a real determiner. It’s patient activities, specifically their desire to return to jumping, 
cutting and pivoting activities. For older patients, it’s reasonable to try PT (physical therapy) first. 
They may be able to cope, especially if they have arthritis as the stiffness associated often 
protects. Regardless of age, if someone is having instability with activities of daily living, they 
are reasonable candidates for ACL reconstruction. Younger patients often would like to return to 
athletic activity and so we typically go right to surgery to protect their knee from further damage. 
For younger, high-activity patients, a ‘stiffer’ graft such as BPTB or quadriceps tendon autograft 
are good options.  For others, hamstring or quadriceps tendons are good options. I think it will 
continue to be close to even split with BTB, HS and QT for autograft. They are all three 
reasonable options. QT is really gaining traction. Will continue to see better fixation methods for 
it. In appropriate candidates, we may see a surge in ACL repair as well. Time will tell if this is a 
better approach than reconstruction. 
The morbidity associated with autograft harvest of the hamstring tendon is an important 
consideration for athletic and daily activities. Loss of knee flexion strength was demonstrated 2 
years post-hamstring autograft ACLR14, and QTPB autograft demonstrated loss of torque at peak 
extension of the quadriceps muscle at 6 months post-operation20. With the disadvantages of 
autografts clarified, the outcomes associated with allografts in ACLR will now be discussed.  
Allografts have indications for those patients who are not as young and active as 
autograft patients. Allografts are a preferred graft choice for patients concerned with the 
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complications of donor-site morbidity associated with ACLR using an autograft like hamstring 
or quadriceps weakness, nerve damage, and anterior knee pain. The literature also demonstrates 
the importance in the type of allograft preservation. Irradiated allografts have shown poor 
stability and increased failure rates, thus would not be a first-line choice for ACLR. Evidence 
from larger studies evaluating arthrometry reveals increased laxity or failure rates in allografts 
compared to autografts. With advantages of allografts including no donor-site morbidity, shorter 
operative time, and graft length selection preoperatively, allografts are increasing in popularity. 
Finally, a patient-centered decision should be at the forefront of surgeons’ agendas. The 
most difficult part of a surgeon’s practice, according to Dr. Weiss, is managing expectations. 
“This is the toughest part of practice. It is important to review realistic expectations but even 
then, patients may not remember or understand. Everyone heals at different rates.  I tell patients 
that the biggest mistake they could make is comparing themselves to others. No other person has 
the exact same situation as theirs so it’s apples to oranges.” The contributing factors for surgical 
intervention are continually evolving, and are not universally agreed upon amongst physicians. 
The type of surgery is based on tear location, tissue quality, age, activity level, and patient 
preference. The first step in deciding the type of surgical treatment is appropriate depends on the 
patient. The data and research aids in the decision-making process for which graft is chosen for 
an ACL tear, but ultimately, it comes down to patient preference, surgeon experience, and 
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APPENDIX 
 




Fig. 2 Showing KT-1000 knee arthrometer 
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